◼ Archived
Health
ASN: Elderly with chronic kidney disease benefit from SGLT2 inhibitors
Coverage from Medical Daily, MedCentral, and pharmaphorum details findings on SGLT2 inhibitors at ASN Kidney Week 2026.
2 trends tracked about this subject — the full history, oldest to newest below.
Coverage from Medical Daily, MedCentral, and pharmaphorum details findings on SGLT2 inhibitors at ASN Kidney Week 2026.
New data presented at ASN indicates SGLT2 inhibitors improve survival and cognitive function for elderly patients with chronic kidney disease.